tirzepatide vision problems #Mounjaro & eyesight…. 2025 reality. The “blindness” stories are mostly about NAION (an eye-stroke). A large study found a very small increase (0.04% vs 0.02%) in people on #semaglutide / #tirzepatide Vision loss risks in patients

7072 In a recent RCT, retatrutide, a potent GLP-1RA agonist in late-stage development, eliminated 86% of fat from the liver in patients with MASLD (Fig

Side effects were reportedly similar to GLP-1 medications, most commonly including gastrointestinal complications like nausea, vomiting and diarrhea

Who should consider taking S-Acetyl Glutathione

CoolSculpting Elite results are designed to be long-lasting because the body gradually eliminates the treated fat cells, and they do not regenerate

Other GLP-1 agonist drugsa class that includes Mounjaro and Zepbound, which have the same active ingredienthave also been approved to reduce the risk of heart attack and stroke in overweight people